1. Home
  2. SLXN vs VRPX Comparison

SLXN vs VRPX Comparison

Compare SLXN & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • VRPX
  • Stock Information
  • Founded
  • SLXN 2008
  • VRPX 2016
  • Country
  • SLXN Israel
  • VRPX United States
  • Employees
  • SLXN N/A
  • VRPX N/A
  • Industry
  • SLXN
  • VRPX Medicinal Chemicals and Botanical Products
  • Sector
  • SLXN
  • VRPX Health Care
  • Exchange
  • SLXN NYSE
  • VRPX Nasdaq
  • Market Cap
  • SLXN 4.3M
  • VRPX 3.6M
  • IPO Year
  • SLXN N/A
  • VRPX 2021
  • Fundamental
  • Price
  • SLXN $0.99
  • VRPX $1.22
  • Analyst Decision
  • SLXN Strong Buy
  • VRPX Hold
  • Analyst Count
  • SLXN 1
  • VRPX 1
  • Target Price
  • SLXN $5.00
  • VRPX N/A
  • AVG Volume (30 Days)
  • SLXN 952.7K
  • VRPX 444.2K
  • Earning Date
  • SLXN 05-21-2025
  • VRPX 05-12-2025
  • Dividend Yield
  • SLXN N/A
  • VRPX N/A
  • EPS Growth
  • SLXN N/A
  • VRPX N/A
  • EPS
  • SLXN N/A
  • VRPX N/A
  • Revenue
  • SLXN N/A
  • VRPX N/A
  • Revenue This Year
  • SLXN N/A
  • VRPX N/A
  • Revenue Next Year
  • SLXN N/A
  • VRPX N/A
  • P/E Ratio
  • SLXN N/A
  • VRPX N/A
  • Revenue Growth
  • SLXN N/A
  • VRPX N/A
  • 52 Week Low
  • SLXN $0.21
  • VRPX $1.08
  • 52 Week High
  • SLXN $13.56
  • VRPX $105.98
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • VRPX 15.84
  • Support Level
  • SLXN N/A
  • VRPX $1.08
  • Resistance Level
  • SLXN N/A
  • VRPX $3.77
  • Average True Range (ATR)
  • SLXN 0.00
  • VRPX 0.41
  • MACD
  • SLXN 0.00
  • VRPX -0.05
  • Stochastic Oscillator
  • SLXN 0.00
  • VRPX 4.16

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About VRPX Virpax Pharmaceuticals Inc.

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Share on Social Networks: